These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 26144267)
21. Spatial enrichment and genomic analyses reveal the link of NOMO1 with amyotrophic lateral sclerosis. Guo J; You L; Zhou Y; Hu J; Li J; Yang W; Tang X; Sun Y; Gu Y; Dong Y; Chen X; Sato C; Zinman L; Rogaeva E; Wang J; Chen Y; Zhang M Brain; 2024 Aug; 147(8):2826-2841. PubMed ID: 38643019 [TBL] [Abstract][Full Text] [Related]
23. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis. Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758 [TBL] [Abstract][Full Text] [Related]
24. N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis. Sirianni AC; Jiang J; Zeng J; Mao LL; Zhou S; Sugarbaker P; Zhang X; Li W; Friedlander RM; Wang X J Neurochem; 2015 Sep; 134(5):956-68. PubMed ID: 26031348 [TBL] [Abstract][Full Text] [Related]
25. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Calingasan NY; Chen J; Kiaei M; Beal MF Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590 [TBL] [Abstract][Full Text] [Related]
26. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. I. The cervical swelling. Davidson TJ; Hartmann HA; Johnson PC J Neuropathol Exp Neurol; 1981 Jan; 40(1):32-6. PubMed ID: 6162920 [TBL] [Abstract][Full Text] [Related]
27. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis. Van Damme P; Robberecht W Curr Opin Neurol; 2013 Oct; 26(5):466-72. PubMed ID: 23945281 [TBL] [Abstract][Full Text] [Related]
28. AMPA receptor-mediated neuronal death in sporadic ALS. Kwak S; Hideyama T; Yamashita T; Aizawa H Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521 [TBL] [Abstract][Full Text] [Related]
29. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Morello G; Guarnaccia M; Spampinato AG; Salomone S; D'Agata V; Conforti FL; Aronica E; Cavallaro S Sci Rep; 2019 Jul; 9(1):9968. PubMed ID: 31292500 [TBL] [Abstract][Full Text] [Related]
30. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? Lambrechts D; Storkebaum E; Carmeliet P Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192 [TBL] [Abstract][Full Text] [Related]
31. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. Sasaki S J Neuropathol Exp Neurol; 2011 May; 70(5):349-59. PubMed ID: 21487309 [TBL] [Abstract][Full Text] [Related]
32. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability. Rozas P; Bargsted L; Martínez F; Hetz C; Medinas DB Neurosci Lett; 2017 Jan; 636():9-15. PubMed ID: 27150076 [TBL] [Abstract][Full Text] [Related]
33. Network analyses reveal novel aspects of ALS pathogenesis. Sanhueza M; Chai A; Smith C; McCray BA; Simpson TI; Taylor JP; Pennetta G PLoS Genet; 2015 Mar; 11(3):e1005107. PubMed ID: 25826266 [TBL] [Abstract][Full Text] [Related]
34. A Study of Gene Expression Changes in Human Spinal and Oculomotor Neurons; Identifying Potential Links to Sporadic ALS. Patel AN; Mathew D Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32325953 [TBL] [Abstract][Full Text] [Related]
35. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Cozzolino M; Pesaresi MG; Gerbino V; Grosskreutz J; Carrì MT Antioxid Redox Signal; 2012 Nov; 17(9):1277-330. PubMed ID: 22413952 [TBL] [Abstract][Full Text] [Related]
36. Glutamate receptors: RNA editing and death of motor neurons. Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749 [TBL] [Abstract][Full Text] [Related]
37. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges. Zhao A; Pan Y; Cai S Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190 [TBL] [Abstract][Full Text] [Related]
38. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Subramanian V; Crabtree B; Acharya KR Hum Mol Genet; 2008 Jan; 17(1):130-49. PubMed ID: 17916583 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. Kumar V; Islam A; Hassan MI; Ahmad F Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371 [TBL] [Abstract][Full Text] [Related]
40. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis. Krokidis MG Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]